The predictive value of laboratory parameters for no‐reflow phenomenon in patients with ST‐elevation myocardial infarction following primary percutaneous coronary intervention: A meta‐analysis
Clinical Cardiology · 2024
DOI: 10.1002/clc.24238 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Clinical Cardiology, 2024. Verfasst von LinLi Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Medicine, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, H…. Hauptthemen laut MEDLINE: ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention, No-Reflow Phenomenon. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation of China, Zhejiang traditional Chinese medicine science and technology plan of China, Key Projects of Zhejiang Province Traditional Chinese Medicine Science and Technology Plan of China.
Abstract (Originalsprache)
To date, the predictive role of laboratory indicators for the phenomenon of no flow is unclear. Hence, our objective was to conduct a meta‐analysis to investigate the association between laboratory parameters and the risk of the no‐reflow phenomenon in patients with ST‐elevation myocardial infarction (STEMI) following primary percutaneous coronary intervention (PCI). This, in turn, aims to offer valuable insights for early clinical prediction of no‐reflow. We searched Pubmed, Embase, and Cochrane Library from the establishment of the database to October 2023. We included case‐control or cohort study that patients with STEMI following primary PCI. We excluded repeated publication, research without full text, incomplete information or inability to conduct data extraction and animal experiments, reviews, and systematic reviews. STATA 15.1 was used to analyze the data. The pooled results indicated that elevated white blood cell (WBC) count (odds ratio [OR] = 1.061, 95% confidence interval [CI]: 1.013–1.112), neutrophil count (OR = 1.324, 95% CI: 1.128–1.553), platelet (PLT) (OR = 1.002, 95% CI: 1.000–1.005), blood glucose (OR = 1.005, 95% CI: 1.002–1.009), creatinine (OR = 1.290, 95% CI: 1.070–1.555), total cholesterol (TC) (OR = 1.022, 95% CI: 1.012–1.032), d ‐dimer (OR = 1.002, 95% CI: 1.001–1.004), and fibrinogen (OR = 1.010, 95% CI: 1.005–1.015) were significantly associated with increased risk of no‐reflow. However, elevated hemoglobin was significantly associated with decreased risk of no‐reflow. In conclusion, our comprehensive analysis highlights the predictive potential of various parameters in assessing the risk of no‐reflow among STEMI patients undergoing PCI. Specifically, WBC count, neutrophil count, PLT, blood glucose, hemoglobin, creatinine, TC, d ‐dimer, and fibrinogen emerged as significant predictors. This refined risk prediction may guide clinical decision‐making, allowing for more targeted and effective preventive measures to mitigate the occurrence of no‐reflow in this patient population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Preventive Medicine, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China.
- Department of Cardiology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
- Department of First Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China.
- Department of Cardiology, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Förderung
- Zhejiang Provincial Natural Science Foundation of China
- Zhejiang traditional Chinese medicine science and technology plan of China
- Key Projects of Zhejiang Province Traditional Chinese Medicine Science and Technology Plan of China
Zitieren
APA
Wang, L., Huang, S., Zhou, Q., Dou, L., & Lin, D. (2024). The predictive value of laboratory parameters for no‐reflow phenomenon in patients with ST‐elevation myocardial infarction following primary percutaneous coronary intervention: A meta‐analysis. Clinical Cardiology. https://doi.org/10.1002/clc.24238
Vancouver
Wang L, Huang S, Zhou Q, Dou L, Lin D. The predictive value of laboratory parameters for no‐reflow phenomenon in patients with ST‐elevation myocardial infarction following primary percutaneous coronary intervention: A meta‐analysis. Clinical Cardiology. 2024. doi:10.1002/clc.24238
BibTeX
@article{Wang2024,
author = {Wang, LinLi and Huang, ShuWei and Zhou, Qiujun and Dou, LiPing and Lin, Dongming},
title = {The predictive value of laboratory parameters for no‐reflow phenomenon in patients with ST‐elevation myocardial infarction following primary percutaneous coronary intervention: A meta‐analysis},
journal = {Clinical Cardiology},
year = {2024},
doi = {10.1002/clc.24238}
}
EUVIMED